The value of percentage free prostate specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria

Simple item page
dc.contributor.authorEzenwa, E.V.
dc.contributor.authorTijani, K.H.
dc.contributor.authorJeje, E.A.
dc.contributor.authorSoriyan, O.O.
dc.contributor.authorOgunjimi, M.A.
dc.date.accessioned2019-11-26T08:59:36Z
dc.date.available2019-11-26T08:59:36Z
dc.date.issued2012
dc.descriptionStaff publicationsen_US
dc.description.abstractObjectives: To assess the value of percentage free prostate-specific antigen (%fPSA) in the detection of prostate cancer among Nigerian men with an intermediate total PSA level (4–10 ng/mL), and to show if the optimum threshold for biopsy is different from Caucasian values when the widely used (six-core, digitally directed) prostate biopsy protocol in Nigerians is applied. Patients and methods: The study included 105 patients aged >50 years, with a palpably benign prostate gland and intermediate levels of total PSA (4–10 ng/mL). These patients had a free PSA assay and a transrectal digitally directed six-core biopsy of the prostate. The %fPSA was calculated and the optimum threshold value for detecting prostate cancer was determined. Results: The mean (SD) age of the patients was 64.4 (6.6) years and their mean (SD) total PSA level was 6.6 (1.7) ng/mL. Of these men 14 (13.3%) had cancer of the prostatedetected by the prostate biopsy. The %fPSA level related directly to sensitivity values but inversely to the specificity and the positive predictive values. The best threshold of %fPSA for detecting cancer in these men was <40%, with a sensitivity of 100%, specificity of 93.4% and a positive predictive value of 70% (P<0.05). Conclusions: In evaluating Nigerian patients with a palpably benign prostate gland and within the intermediate total PSA range, when digitally directed biopsy protocol is adopted, a %fPSA threshold of <40% will detect significant percentage of those with prostate cancer, with a minimal number of unnecessary biopsies. This value differs from that reported in western studies in which transrectal ultrasonography- directed biopsy was useden_US
dc.identifier.citationEzenwa EV, Tijani KH, Jeje EA, Soriyan OO, Ogunjimi MA. The value of percentage free prostate specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeria. Arab Journal of Urology 2012;10:394–401en_US
dc.identifier.issn2090-598X
dc.identifier.otherdx.doi.org/10.1016/j.aju.2012.05.004
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/6973
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofseriesArab Journal of Urology;Vol.10
dc.subjectprostate canceren_US
dc.subjectProstate specific antigenen_US
dc.subjectFree PSAen_US
dc.subjectNigerian menen_US
dc.subjectResearch Subject Categories::MEDICINE::Surgeryen_US
dc.titleThe value of percentage free prostate specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in Nigeriaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ezenwa free PSA.pdf
Size:
562.08 KB
Format:
Adobe Portable Document Format
Description:
main article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Surgery- Scholarly Publications